{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T13:16:03Z","timestamp":1776777363548,"version":"3.51.2"},"reference-count":62,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.vaccine.2017.10.078","type":"journal-article","created":{"date-parts":[[2017,11,7]],"date-time":"2017-11-07T15:17:05Z","timestamp":1510067825000},"page":"7174-7180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Post-exposure immunization by capsid-modified AdC7 vector expressing Pseudomonas aeruginosa OprF clears P. aeruginosa respiratory infection"],"prefix":"10.1016","volume":"35","author":[{"given":"Rika","family":"Gomi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anurag","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenzhu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biin","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Worgall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.10.078_b0005","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4046\/trd.2014.77.4.172","article-title":"Recurrent Pseudomonas aeruginosa infection in chronic lung diseases: relapse or reinfection?","volume":"77","author":"Yum","year":"2014","journal-title":"Tuberc Resp Dis"},{"key":"10.1016\/j.vaccine.2017.10.078_b0010","series-title":"Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics","author":"Tacconelli","year":"2017"},{"key":"10.1016\/j.vaccine.2017.10.078_b0015","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1586\/14760584.2014.890053","article-title":"Vaccines for Pseudomonas aeruginosa: a long and winding road","volume":"13","author":"Priebe","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.10.078_b0020","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1128\/IAI.01139-10","article-title":"Mucosal vaccination with a multivalent, live-attenuated vaccine induces multifactorial immunity against Pseudomonas aeruginosa acute lung infection","volume":"79","author":"Kamei","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.10.078_b0025","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/cei.12101","article-title":"RGD capsid modification enhances mucosal protective immunity of a non-human primate adenovirus vector expressing Pseudomonas aeruginosa OprF","volume":"173","author":"Krause","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2017.10.078_b0030","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.vaccine.2010.12.087","article-title":"Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF","volume":"29","author":"Krause","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.10.078_b0035","doi-asserted-by":"crossref","first-page":"999","DOI":"10.4161\/hv.7.10.16369","article-title":"Recent developments for Pseudomonas vaccines","volume":"7","author":"Sharma","year":"2011","journal-title":"Human Vaccines"},{"key":"10.1016\/j.vaccine.2017.10.078_b0040","doi-asserted-by":"crossref","first-page":"13801","DOI":"10.1128\/JVI.01246-07","article-title":"Protective immunity to Pseudomonas aeruginosa induced with a capsid-modified adenovirus expressing P. aeruginosa OprF","volume":"81","author":"Worgall","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.10.078_b0045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4161\/hv.34296","article-title":"Vaccination against respiratory Pseudomonas aeruginosa infection","volume":"11","author":"Grimwood","year":"2015","journal-title":"Human Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2017.10.078_b0050","first-page":"307","article-title":"Gene-based vaccine approaches for respiratory syncytial virus","volume":"372","author":"Loomis","year":"2013","journal-title":"Curr Topics Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2017.10.078_b0055","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1080\/21645515.2015.1016674","article-title":"Progress on adenovirus-vectored universal influenza vaccines","volume":"11","author":"Xiang","year":"2015","journal-title":"Human Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2017.10.078_b0060","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tube.2006.01.017","article-title":"Use of recombinant virus-vectored tuberculosis vaccines for respiratory mucosal immunization","volume":"86","author":"Xing","year":"2006","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.vaccine.2017.10.078_b0065","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1021\/mp500646d","article-title":"A single dose respiratory recombinant adenovirus-based vaccine provides long-term protection for non-human primates from lethal ebola infection","volume":"12","author":"Choi","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1016\/j.vaccine.2017.10.078_b0070","article-title":"Potential of protein OprF of Pseudomonas in bivalent vaccines","volume":"283\u201390","author":"Hancock","year":"1997","journal-title":"Behring Inst Mitt"},{"key":"10.1016\/j.vaccine.2017.10.078_b0075","doi-asserted-by":"crossref","first-page":"e56996","DOI":"10.1371\/journal.pone.0056996","article-title":"Adenovirus-based vaccine with epitopes incorporated in novel fiber sites to induce protective immunity against Pseudomonas aeruginosa","volume":"8","author":"Sharma","year":"2013","journal-title":"PloS one"},{"key":"10.1016\/j.vaccine.2017.10.078_b0080","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1172\/JCI23135","article-title":"Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid","volume":"115","author":"Worgall","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2017.10.078_b0085","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/156652311796150372","article-title":"Adenoviral vector immunity: its implications and circumvention strategies","volume":"11","author":"Ahi","year":"2011","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.vaccine.2017.10.078_b0090","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1128\/JVI.70.11.7498-7509.1996","article-title":"Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy","volume":"70","author":"Mittereder","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.10.078_b0095","doi-asserted-by":"crossref","unstructured":"Facchini M, De Fino I, Riva C, Bragonzi A. Long term chronic Pseudomonas aeruginosa airway infection in mice. J Visualized Exp: JoVE 2014.","DOI":"10.3791\/51019"},{"key":"10.1016\/j.vaccine.2017.10.078_b0100","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/icb.1995.65","article-title":"Pulmonary immunity to Pseudomonas aeruginosa","volume":"73","author":"Cripps","year":"1995","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2017.10.078_b0105","unstructured":"Cystic Fibrosis Foundation Patient Registry. Annual data report; 2015."},{"key":"10.1016\/j.vaccine.2017.10.078_b0110","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijantimicag.2015.03.001","article-title":"Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology","volume":"45","author":"Potron","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.vaccine.2017.10.078_b0115","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1513\/AnnalsATS.201404-166OC","article-title":"Cystic Fibrosis Foundation pulmonary guideline. pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection","volume":"11","author":"Mogayzel","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.vaccine.2017.10.078_b0120","doi-asserted-by":"crossref","unstructured":"Zhu S, Guo C. Rabies control and treatment: from prophylaxis to strategies with curative potential. Viruses 2016;8.","DOI":"10.3390\/v8110279"},{"key":"10.1016\/j.vaccine.2017.10.078_b0125","doi-asserted-by":"crossref","first-page":"S360","DOI":"10.1093\/infdis\/jiw218","article-title":"Efficacy of vesicular stomatitis virus-ebola virus postexposure treatment in rhesus macaques infected with ebola virus makona","volume":"214","author":"Marzi","year":"2016","journal-title":"J Inf Dis"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2017.10.078_b0130","doi-asserted-by":"crossref","first-page":"S379","DOI":"10.1093\/infdis\/jiv102","article-title":"Adenovirus-vectored vaccine provides postexposure protection to ebola virus-infected nonhuman primates","volume":"212","author":"Wong","year":"2015","journal-title":"J Inf Dis"},{"key":"10.1016\/j.vaccine.2017.10.078_b0135","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/pch\/21.2.91","article-title":"Vaccines for postexposure prophylaxis against varicella (chickenpox) in children and adults","volume":"21","author":"McDonald","year":"2016","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.vaccine.2017.10.078_b0140","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1615\/JEnvironPatholToxicolOncol.v29.i4.30","article-title":"Postexposure prophylaxis for deadly bloodborne viral infections","volume":"29","author":"Edlich","year":"2010","journal-title":"J Environ Pathol, Toxicol Oncol: Off Organ Int Soc Environ Toxicol Cancer"},{"key":"10.1016\/j.vaccine.2017.10.078_b0145","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1128\/IAI.01121-12","article-title":"Postexposure subunit vaccination against chronic enteric mycobacterial infection in a natural host","volume":"81","author":"Santema","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.10.078_b0150","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1258\/0023677054306944","article-title":"Cystic fibrosis lung disease following infection with Pseudomonas aeruginosa in Cftr knockout mice using novel non-invasive direct pulmonary infection technique","volume":"39","author":"Guilbault","year":"2005","journal-title":"Lab Animals"},{"key":"10.1016\/j.vaccine.2017.10.078_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1165\/rcmb.2006-0184TR","article-title":"Cystic fibrosis mouse models","volume":"36","author":"Guilbault","year":"2007","journal-title":"Am J Resp Cell Mol Biol"},{"key":"10.1016\/j.vaccine.2017.10.078_b0160","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/infdis\/jis636","article-title":"Response of CFTR-deficient mice to long-term chronic Pseudomonas aeruginosa infection and PTX3 therapy","volume":"208","author":"Paroni","year":"2013","journal-title":"J Inf Dis"},{"key":"10.1016\/j.vaccine.2017.10.078_b0165","first-page":"453","article-title":"A rat model of chronic respiratory infection with Pseudomonas aeruginosa","volume":"119","author":"Cash","year":"1979","journal-title":"Am Rev Resp Dis"},{"key":"10.1016\/j.vaccine.2017.10.078_b0170","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jcf.2010.12.007","article-title":"Characterisation of a refined rat model of respiratory infection with Pseudomonas aeruginosa and the effect of ciprofloxacin","volume":"10","author":"Growcott","year":"2011","journal-title":"J Cystic Fibrosis: Off J Eur Cystic Fibrosis Soc"},{"key":"10.1016\/j.vaccine.2017.10.078_b0175","first-page":"362","article-title":"A role for CD4+ T cells from orally immunized rats in enhanced clearance of Pseudomonas aeruginosa from the lung","volume":"83","author":"Dunkley","year":"1994","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2017.10.078_b0180","first-page":"771","article-title":"Immunity to respiratory Pseudomonas aeruginosa infection: the role of gut-derived T helper cells and immune serum","volume":"371B","author":"Dunkley","year":"1995","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2017.10.078_b0185","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1365-2249.1995.tb03478.x","article-title":"In vitro and in vivo T cell responses in mice during bronchopulmonary infection with mucoid Pseudomonas aeruginosa","volume":"99","author":"Stevenson","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2017.10.078_b0190","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1574-6968.1993.tb06524.x","article-title":"Conservation of surface epitopes in Pseudomonas aeruginosa outer membrane porin protein OprF","volume":"113","author":"Martin","year":"1993","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.vaccine.2017.10.078_b0195","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1128\/IAI.66.8.3990-3994.1998","article-title":"A chimeric influenza virus expressing an epitope of outer membrane protein F of Pseudomonas aeruginosa affords protection against challenge with P. aeruginosa in a murine model of chronic pulmonary infection","volume":"66","author":"Staczek","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.10.078_b0200","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/978-1-61779-120-8_19","article-title":"Comparative biology of cystic fibrosis animal models","volume":"742","author":"Fisher","year":"2011","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2017.10.078_b0205","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1128\/IAI.73.4.2504-2514.2005","article-title":"Novel mouse model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis","volume":"73","author":"Hoffmann","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.10.078_b0210","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nrmicro3360","article-title":"Novel vaccine vectors for HIV-1","volume":"12","author":"Barouch","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2017.10.078_b0215","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1586\/14760584.2015.1077122","article-title":"Adenovirus-vectored Ebola vaccines","volume":"14","author":"Gilbert","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.10.078_b0220","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2174\/1566523213666131125095046","article-title":"Adenovirus vectors for gene therapy, vaccination and cancer gene therapy","volume":"13","author":"Wold","year":"2013","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.vaccine.2017.10.078_b0225","doi-asserted-by":"crossref","first-page":"16030","DOI":"10.1038\/mtm.2016.30","article-title":"Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens","volume":"3","author":"Afkhami","year":"2016","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.vaccine.2017.10.078_b0230","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/1570162X14999160224103025","article-title":"Mucosal vaccination for prevention of HIV infection and AIDS","volume":"14","author":"Aldovini","year":"2016","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.vaccine.2017.10.078_b0235","doi-asserted-by":"crossref","first-page":"15","DOI":"10.7774\/cevr.2017.6.1.15","article-title":"The development of mucosal vaccines for both mucosal and systemic immune induction and the roles played by adjuvants","volume":"6","author":"Kim","year":"2017","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.vaccine.2017.10.078_b0240","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2017.10.078_b0245","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.vaccine.2005.08.045","article-title":"Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children","volume":"24","author":"Wong-Chew","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.10.078_b0250","first-page":"7913","article-title":"Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells","volume":"61","author":"Okada","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.vaccine.2017.10.078_b0255","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1128\/JVI.78.5.2572-2580.2004","article-title":"Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses","volume":"78","author":"Worgall","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.10.078_b0260","doi-asserted-by":"crossref","DOI":"10.1089\/hum.2016.139","article-title":"Induction of oxidants distinguishes susceptibility of prostate carcinoma cell lines to p53 gene transfer mediated by an improved adenoviral vector","author":"Tamura","year":"2017","journal-title":"Human Gene Ther"},{"key":"10.1016\/j.vaccine.2017.10.078_b0265","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/WNR.0b013e3283088e3d","article-title":"Th1 cytokines are upregulated by adenoviral vectors in the brains of primed mice","volume":"19","author":"Lee","year":"2008","journal-title":"Neuroreport"},{"key":"10.1016\/j.vaccine.2017.10.078_b0270","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1128\/CVI.00311-10","article-title":"The Th1 immune response to Plasmodium falciparum circumsporozoite protein is boosted by adenovirus vectors 35 and 26 with a homologous insert","volume":"17","author":"Radosevic","year":"2010","journal-title":"Clin Vaccine Immunol: CVI"},{"key":"10.1016\/j.vaccine.2017.10.078_b0275","first-page":"269","article-title":"Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle","author":"Johansen","year":"1997","journal-title":"Behring Inst Mitteilungen"},{"key":"10.1016\/j.vaccine.2017.10.078_b0280","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jaci.2005.09.023","article-title":"Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis","volume":"117","author":"Hartl","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2017.10.078_b0285","first-page":"329","article-title":"The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type. APMIS: acta pathologica, microbiologica, et immunologica","volume":"108","author":"Moser","year":"2000","journal-title":"Scandinavica"},{"key":"10.1016\/j.vaccine.2017.10.078_b0290","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nm.2715","article-title":"Cystic fibrosis: a mucosal immunodeficiency syndrome","volume":"18","author":"Cohen","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2017.10.078_b0295","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1165\/rcmb.2012-0021OC","article-title":"Low sphingosine-1-phosphate impairs lung dendritic cells in cystic fibrosis","volume":"48","author":"Xu","year":"2013","journal-title":"Am J Resp Cell Mol Biol"},{"key":"10.1016\/j.vaccine.2017.10.078_b0300","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.4049\/jimmunol.181.7.4965","article-title":"IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa","volume":"181","author":"Priebe","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.10.078_b0305","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1128\/IAI.00717-16","article-title":"Interleukin-17 Is required for control of chronic lung infection caused by Pseudomonas aeruginosa","volume":"84","author":"Bayes","year":"2016","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.10.078_b0310","doi-asserted-by":"crossref","first-page":"25937","DOI":"10.1038\/srep25937","article-title":"IL-17A impairs host tolerance during airway chronic infection by Pseudomonas aeruginosa","volume":"6","author":"Lore","year":"2016","journal-title":"Sci Rep"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1731486X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1731486X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T07:49:40Z","timestamp":1603266580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1731486X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":62,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0264410X1731486X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.078","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-exposure immunization by capsid-modified AdC7 vector expressing Pseudomonas aeruginosa OprF clears P. aeruginosa respiratory infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}